What is Humist Moisturizing Mist?
Humist Moisturizing Mist is the chemical name for salt. Humist Moisturizing Mist can reduce some types of bacteria in certain body secretions, such as saliva.
Humist Moisturizing Mist inhalation is used to produce sputum (mucus, or phlegm) from the mouth to help improve lung function in people with cystic fibrosis, or to collect sputum for medical testing. This medication may also be used to dilute other medications inhaled through a nebulizer.
Humist Moisturizing Mist inhalation may also be used for other purposes not listed in this medication guide.
Humist Moisturizing Mist indications
Airlife Modudose Humist Moisturizing Mist as isotonic solution: the dehydration of various origins. To maintain the volume of blood plasma during and after surgery. As a solvent for various drugs.
Hypertonic solution: violations of water-electrolyte metabolism: lack of sodium and chlorine ions; hypoosmotic dehydration of various origins (due to prolonged vomiting, diarrhea, burns with a gastric fistula, pulmonary hemorrhage, intestinal bleeding).
Eye drops and ointment: irritation of the cornea with inflammatory and allergic diseases (combined therapy).
How should I use Humist Moisturizing Mist?
Use Humist Moisturizing Mist nebulizer solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Humist Moisturizing Mist nebulizer solution is for inhalation in a nebulizer only. Do not take Humist Moisturizing Mist nebulizer solution by mouth or inject it.
- Humist Moisturizing Mist nebulizer solution is used to dilute other medicines. Follow the instructions provided by your doctor.
- Humist Moisturizing Mist nebulizer solution may come in a single-dose vial or in a container with multiple doses. Be sure to use the proper amount of Humist Moisturizing Mist nebulizer solution. If you are using Humist Moisturizing Mist nebulizer solution from a multiple-dose container, use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.
- If you are using a vial, use your dose immediately after opening the vial and throw away any unused medicine. Do not save the contents of an opened vial for later use.
- Do not use Humist Moisturizing Mist nebulizer solution if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.
- This product is intended to dilute other medicines for use in a nebulizer. If you miss a dose of your medicine, follow the missed dose instructions for the medicine that you are mixing with this product.
Ask your health care provider any questions you may have about how to use Humist Moisturizing Mist nebulizer solution.
Uses of Humist Moisturizing Mist in details
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier.
This product contains a purified gentle salt solution (also called saline or Humist Moisturizing Mist solution). It does not contain any medication.
How to use Humist Moisturizing Mist nasal
Spray this product into each nostril as needed or as directed by your doctor. This product may also be given into the nose as drops or a stream. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.
Try not to touch the container tip to the inside of your nose. If this happens, rinse the tip with hot water and dry with a clean tissue before recapping the container.
If your condition persists or worsens, or if you think you may have a serious medical problem, seek immediate medical attention.
Humist Moisturizing Mist description
Humist Moisturizing Mist, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Humist Moisturizing Mist is the salt most responsible for the salinity of seawater and of the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.
Humist Moisturizing Mist dosage
All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment.
As directed by a physician. Dosage, rate, and duration of administration are to be individualized and depend upon the indication for use, the patient’s age, weight, clinical condition, concomitant treatment, and on the patient’s clinical and laboratory response to treatment.
When other electrolytes or medicines are added to this solution, the dosage and the infusion rate will also be dictated by the dose regimen of the additions.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Use of a final filter is recommended during administration of all parenteral solutions, where possible.
Do not administer unless the solution is clear and seal is intact.
Additives may be incompatible with Humist Moisturizing Mist Injection, USP. As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition. Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Humist Moisturizing Mist Injection, USP is appropriate. After addition, check for unexpected color changes and/or the appearance of precipitates, insoluble complexes or crystals.
The instructions for use of the medication to be added and other relevant literature must be consulted. Additives known or determined to be incompatible must not be used. When introducing additives to Humist Moisturizing Mist Injection, USP, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives.
After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion. Do not reconnect any partially used containers. Discard any unused portion.
Humist Moisturizing Mist interactions
See also:
What other drugs will affect Humist Moisturizing Mist?
Caution must be exercised in the administration of Humist Moisturizing Mist Injection, USP to patients receiving corticosteroids or corticotropin.
Studies have not been conducted to evaluate additional drug/drug or drug/food interactions with Humist Moisturizing Mist (Humist Moisturizing Mist (Humist Moisturizing Mist injection) injection) Injection, USP.
Humist Moisturizing Mist side effects
See also:
What are the possible side effects of Humist Moisturizing Mist?
Post-Marketing Adverse Reactions
The following adverse reactions have been identified during postapproval use of Humist Moisturizing Mist Injection, USP. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
The following adverse reactions have been reported in the post-marketing experience during use of 0.9% Humist Moisturizing Mist Injection, USP and include the following:
hypersensitivity/infusion reactions, including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus.
Also reported are infusion site reactions, such as infusion site erythema, injection site streaking, burning sensation, and infusion site urticaria.
The following adverse reactions have not been reported with 0.9% Humist Moisturizing Mist Injection, USP but may occur: hypernatremia, hyperchloremic metabolic acidosis, and hyponatremia, which may be symptomatic.
Hyponatremia has been reported for 0.45% Humist Moisturizing Mist Injection, USP.
The following adverse reactions have not been reported with 0.45% Humist Moisturizing Mist Injection, USP but may occur: hyperchloremic metabolic acidosis, hypersensitivity/infusion reactions (including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus), and infusion site reactions (such as infusion site erythema, injection site streaking, burning sensation, infusion site urticaria).
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Humist Moisturizing Mist contraindications
See also:
What is the most important information I should know about Humist Moisturizing Mist?
Due to potential toxicity of benzyl alcohol in newborns, Bacteriostatic Humist Moisturizing Mist Injection, USP, 0.9% containing benzyl alcohol must not be used in this patient population.
Bacteriostatic Humist Moisturizing Mist Injection, USP, 0.9% should not be used for fluid or Humist Moisturizing Mist replacement.
Active ingredient matches for Humist Moisturizing Mist:
Sodium chloride in United States.
List of Humist Moisturizing Mist substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| HuMist Nasal Mist (United States) | |
| Hydralarm (France) | |
| Hydrocare Preserved Saline (New Zealand) | |
| HYNASAL (India) | |
| 0.65 % w/v x 15ml (DWD Pharmaceuticals Ltd.) | $ 0.30 |
| Hynasal 0.65% w/v N-DPS / 15ml (DWD Pharmaceuticals Ltd.) | $ 0.30 |
| Hynasal Nasal 15 ml Drop (DWD Pharmaceuticals Ltd.) | $ 0.02 |
| HYNASAL nasal drops 0.65 % w/v x 15ml (DWD Pharmaceuticals Ltd.) | $ 0.30 |
| Hynasal 0.65% w/v N-DPS / 15ml (DWD Pharmaceuticals Ltd.) | $ 0.30 |
| HYNASAL DPS. | |
| HYNASAL DPS. Drops / 0.0065 / 15ml units (DWD Pharmaceuticals) | $ 0.22 |
| Hyper-Sal | |
| Hypergel (France, Australia, Canada) | |
| Hypersal | |
| Hypersalt (Philippines) | |
| Hypersalt 50 mg/1 mL x 10 mL (Vista Pharma) | |
| Hypersalt eye drops 50 mg/mL 10 mL x 1's (Vista Pharma) | |
| HYPERSOL-6 (India) | |
| 6 % w/w x 10g (Jawa) | $ 1.31 |
| Hypersol-6 6% w/w OINT / 3g (Jawa) | $ 1.59 |
| HYPERSOL-6 eye oint 6 % w/w x 3g (Jawa) | $ 1.76 |
| Hypersol-6 6% w/w OINT / 3g (Jawa) | $ 1.59 |
| Hypertone Natriumchlorid-Lösung (Austria, Germany) | |
| Hypertone Natriumchlorid-Lösung 7,5 g/100ml für Nutztiere, Hunde und Katzen (Austria) | |
| Hypertonic 7.2% (United Kingdom) | |
| Hyposaline | |
| In A Wink Daily Cleaner | |
| In A Wink Neutralizing Rinse | |
| Infusio Natrii Chlorati Isotonica Imuna (Slovakia) | |
| Infusio Natrii Chlorati Isotonica Mediekos F 1/1 (Czech Republic) | |
| Inj. Natrii chlorati 10% Polpharma (Poland) | |
| Injectio Natrii chlorati isotonica Polpharma (Poland) | |
| Insaline (India) | |
| Insaline 5% w/v EYE-DPS / 10ml (Sunways) | |
| INSALINE eye drops 5 % w/v x 10ml (Sunways) | |
| INTASOL (India) | |
| 500ml (Intas) | $ 1.13 |
| INTASOL INFUSION 1 bottle / 500 ML infusion each (Intas) | $ 2.89 |
| INTASOL INFUSION 1 bottle / 250 ML infusion each (Intas) | $ 0.91 |
| INTASOL infusion 500ml (Intas) | $ 1.13 |
| Intasol Infusion (Intas) | $ 0.00 |
| Intraperitoneal Dialysis Fluid | |
| Intraperitoneal Dialysis Fluid 1000 ml Infusion (Parenteral Drugs (India) Ltd.) | $ 0.05 |
| Intraperitoneal Dialysis Fluid 2000 ml Infusion (Parenteral Drugs (India) Ltd.) | $ 0.04 |
| IRIGAN (India) | |
| 100ml (Klar Sehen Pharmaceuticals Pvt Ltd) | $ 0.35 |
| Irigan 100 ml Solution (Klar Sehen Pharmaceuticals Pvt Ltd) | $ 0.47 |
| IRIGAN SOLUTION 1 bottle / 500 ML solution each (Klar Sehen Pharmaceuticals Pvt Ltd) | $ 1.91 |
| IRIGAN eye soln 100ml (Klar Sehen Pharmaceuticals Pvt Ltd) | $ 0.35 |
| Irigate (United States) | |
See 1611 substitutes for Humist Moisturizing Mist | |
References
- DailyMed. "AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "sodium chloride". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Sodium Chloride". http://www.drugbank.ca/drugs/DB09153 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Humist Moisturizing Mist are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Humist Moisturizing Mist. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
